Procedure
DC Cardioversion
DC Cardioversion is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
NCT06096246
completednot_applicable
Investigation of Therapeutic Ablation Versus Cardioversion for AF
NCT03907982
completedphase_4
Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation
NCT02528604
Clinical Trials (3)
Showing 3 of 3 trials
NCT06096246Not Applicable
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
NCT03907982Not Applicable
Investigation of Therapeutic Ablation Versus Cardioversion for AF
NCT02528604Phase 4
Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3